BEYOND THERAPEUTIC BENEFITS: KAJIAN FARMAKOVIGILANS EFEK SAMPING KORTIKOSTEROID DI INDONESIA
DOI:
https://doi.org/10.36387/vv82rt22Keywords:
Pharmacovigilance, corticosteroids, side effects, Drug Rationale , IndonesiaAbstract
Corticosteroids are widely used in clinical practice in Indonesia for the treatment of various diseases. However, prolonged and/or high-dose corticosteroid therapy may lead to serious adverse effects that negatively affect patients’ quality of life. Monitoring of corticosteroid-related adverse drug reactions in Indonesia remains limited, highlighting the need for a pharmacovigilance approach to identify, assess, monitor, and prevent undesirable drug-related events. This review aimed to provide a comprehensive overview of adverse effects associated with corticosteroid use in Indonesia as a basis for safe, effective, and rational therapeutic decision-making. Literature searches were conducted through ScienceDirect, PubMed, Google Scholar, and manual searches using the keywords “pharmacovigilance,” “corticosteroid,” “side effect,” “adverse effect,” and “Indonesia” based on predefined inclusion and exclusion criteria. A total of eight eligible articles were critically analyzed, covering various corticosteroid dosage forms, patient characteristics, and the types and severity of adverse effects. The findings showed that adverse reactions ranged from mild to severe, with increased risk associated with long-term and high-dose corticosteroid use. This review emphasizes the importance of pharmacovigilance in improving healthcare professionals’ awareness and promoting rational corticosteroid use in Indonesia
References
1. Suardamana K, Setiawan G. Aspek Farmakologi dan Indikasi Corticosteroid. Vol. 50. 2023.
2. Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi:10.1038/s41392-021-00658-5
3. Janahi IA, Rehman A, Baloch NUA. Corticosteroids and Their Use in Respiratory Disorders. In: Corticosteroids. InTech; 2018. doi:10.5772/intechopen.72147
4. Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. Clin Ther. 2017 Nov;39(11):2216–29. doi:10.1016/j.clinthera.2017.09.011
5. Alan IS, Alan B. Side Effects of Glucocorticoids. In: Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. InTech; 2018. doi:10.5772/intechopen.72019
6. Williams DM. Clinical Pharmacology of Corticosteroids. Respir Care. 2018 Jun 24;63(6):655–70. doi:10.4187/respcare.06314
7. Lucas S, Ailani J, Smith TR, Abdrabboh A, Xue F, Navetta MS. Pharmacovigilance: reporting requirements throughout a product’s lifecycle. Ther Adv Drug Saf. 2022 Jan 27;13:204209862211250. doi:10.1177/20420986221125006
8. Pradhani Dhaneswari. Analisis Pola Pembelian Obat Kortikosteroid dalam Swamedikasi di Apotek Pada Masyarakat Trimulyo, Jetis, Bantul. Jurnal Kesehatan Madani Medika. 2024;15(02).
9. Hamid AAA, Rahim R, Teo SP. Pharmacovigilance and Its Importance for Primary Health Care Professionals. Korean J Fam Med. 2022 Sep 20;43(5):290–5. doi:10.4082/kjfm.21.0193
10. Mwakawanga DL, Kilonzi M, Philipo EG, Martine A, Mbilinyi T, Kileo NF, et al. Pharmacovigilance and Adverse Drug Reactions Reporting: Healthcare Providers’ Experiences from Southern Highland Tanzania. Adv Pharmacol Pharm Sci. 2023 Oct 16;2023:1–10. doi:10.1155/2023/5537592
11. Anwar Suwandi K, Yuliwulandari R, Drissa Hasibuan F, Kunci K. Gambaran Efek Samping Penggunaan Kortikosteroid Jangka Panjang Pada Pasien Systemic Lupus Erythematosus (SLE) Di Rumah Sakit Umum Daerah Pasar Rebo Periode Overview Of Long Term Corticosteroid Use Side Effect In Systemic Lupus Erythematosus (SLE) Patients At Regional General Hospital Pasar Rebo. Junior Medical Journal. 2022;1(1).
12. Hetti Rusmini, Syamsiatul Ma’rifah. Gambaran Penggunaan Kortikosteroid Sistemik Jangka Panjang Terhadap Kejadian Katarak di Poli Mata Rumah Sakit Pertamina Bintang Amin Bandar Lampung. Jurnal Ilmu Kedokteran dan Kesehatan. 2017;4(2).
13. Febrina D, Hindritiani R, Ruchiatan K, Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran Universitas Padjajaran D, Hasan Sadikin R. Laporan Kasus: Efek Samping Kortikosteroid Topikal Jangka Lama pada Wajah. Syifa Medika. 2018;8(2).
14. Putri JG, Wisan AB. Efek Samping Terapi Kortikosteroid Sistemik Jangka Panjang pada Pasien Lupus Erimatosus Sistemik dan Tatalaksana Dermatologi. Vol. 47. 2020.
15. Husna I, Ramatillah DL, Anggraeni YD. Evaluasi Efek Samping Penggunaan Obat Tetes Mata Kortikosteroid Pada Pasien Pasca Operasi Di Instalasi Farmasi Rumah Sakit Mata Jakarta Eye Center Kedoya. Archives Pharmacia. 2019;1:41.
16. Siagian JN, Purwantyastuti, Instiaty, Menaldi SL. Analysis of therapeutic effectiveness and adverse effects of long-term corticosteroids among leprosy patients with reactions: A retrospective cohort study. SAGE Open Med. 2022 Apr 1;10. doi:10.1177/20503121221089448
17. Mira Indramaya D, Karim A, Ahmad Z. A Case of Tinea Incognito: A Misuses of Steroid. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2019;31(3).
18. Octaviani CD. A Case Report: Red Skin Syndrome- as the Rebound Effect of Using a Long Term Potent Topical Corticosteroid. Indonesian Journal of Clinical Pharmacy. 2014 Jun;3(2):50–4. doi:10.15416/ijcp.2014.3.2.50
19. Luo J, Chang F, Chen T, Ng Y, Lin H, Lu C, et al. Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy. Br J Clin Pharmacol. 2009 Aug 7;68(2):252–9. doi:10.1111/j.1365-2125.2009.03445.x
20. Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014 May;4(5):e004587. doi:10.1136/bmjopen-2013-004587
21. García-Guevara G, Ríos-Corzo R, Díaz-Mora A, López-López M, Hernández-Flores J, Fragoso-Loyo H, et al. Pneumonia in patients with systemic lupus erythematosus: Epidemiology, microbiology and outcomes. Lupus. 2018 Oct 12;27(12):1953–9. doi:10.1177/0961203318799207
22. Kuo T, McQueen A, Chen TC, Wang JC. Regulation of Glucose Homeostasis by Glucocorticoids. In: 10.1007/978-1-4939-2895-8_5. 2015. p. 99–126. doi:10.1007/978-1-4939-2895-8_5
23. Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid‐induced posterior subcapsular cataracts. Clin Exp Optom. 2002 Mar 1;85(2):61–75. doi:10.1111/j.1444-0938.2002.tb03011.x
24. Lee SW, Jin KH, Lee SC, Cho BS, Park SS. Cataract and glaucoma in Korean children with chronic glomerulonephritis receiving systemic corticosteroid treatment. Acta Ophthalmol. 2010 Dec 29;88(8). doi:10.1111/j.1755-3768.2009.01816.x
25. Nerome Y, Imanaka H, Nonaka Y, Takei S, Kawano Y. Frequent methylprednisone pulse therapy is a risk factor for steroid cataracts in children. Pediatrics International. 2008 Aug 25;50(4):541–5. doi:10.1111/j.1442-200X.2008.02629.x
26. Inayati Raisania, Muryawan, Adhie Nur Radityo. Hubungan Antara Terapi Kortikosteroid Dengan Kejadian Katarak Pada Anak Dengan Sindrom Nefrotik. Semantic Scholar. 2012.
27. Lowell A. Goldsmith, Stephen I. Katz, Barbara A. Gilchrest, Amy S. Paller, David J. Leffell, Klaus Wolff. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill Education; 2012.
28. Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-Induced Adverse Events in Adults. Drug Saf. 2007;30(10):861–81. doi:10.2165/00002018-200730100-00005
29. Wirastuti A, A. Noe Y, Rahmawati R. Pengaruh Kualitas Kefarmasian terhadap Pelayanan di Apotek RSIA Ananda Trifa Kota Parepare. Jurnal Insan Farmasi Indonesia. 2021 May 30;4(1):7–14. doi:10.36387/jifi.v4i1.668
30. Yuwindry I, Yusri Y, Tangkas HH. Kajian Dampak Efek Samping Penggunaan Obat Off Label Pada Pasien Sistemik Lupus Eritematosus (SLE) terhadap Biaya Kesehatan. Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan. 2023 Oct 31;8(2):176–84. doi:10.36387/jiis.v8i2.1313
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Insan Farmasi Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
